Xbira 250mg Tablet

• There are various side effects of consuming the Xbira 250mg tablet. They may vary from person to person depending on the health and age of the person. Consult your doctor immediately in case these side effects worsen. 
• Swelling of a joint
  
• General discomfort
  
• Low potassium levels in the blood (may cause muscle weakness, twitches, or pounding heartbeat)
  
• Swelling (legs, feet, or other areas)
  
• Frequent urination at night
  
• Indigestion
  
• Muscle pain
  
• Fluid buildup in legs or feet
  
• High blood pressure
  
• Urinary tract infection
  
• Diarrhea
  
• High fat levels in the blood (dyslipidemia)
  
• Chest pain
  
• Irregular heartbeat
  
• Rapid heart rate
  
• Bone fracture
• ​Blood in urine
• ​Rash

• The doctor determines the dosage of Xbira 250mg Tablet as per the patient's health and other medical conditions.
• Take it at a fixed time every day exactly as prescribed by the doctor to get effective results.
• This medicine should be taken orally on an empty stomach.
  
• Avoid breaking the tablets by swallowing them whole with water.
  
• Pregnant or potentially pregnant women should not handle this medicine without gloves.
• In case of an overdose, contact your doctor immediately

• Xbira 250mg Tablet is an anticancer medicine prescribed to treat prostate cancer.
• It works by blocking the action of an enzyme called CYP17.
• This enzyme is involved in the production of the male hormone androgen, as some prostate cancer depends on these hormones to grow, and this medicine effectively slows down or stops the progression of cancer by inhibiting the action of this enzyme.
• In this way this tablet cuts off the fuel supply that the cancer cells need to survive.

• In case of a missed dose, contact your healthcare provider. 
  

​

• Inform the doctor about your medical history of liver problems, blood pressure, heart disorders, diabetes, or taking any medication for these medical conditions.
• Xbira 250mg Tablet is used in adult men to treat advanced prostate cancer that has spread, often together with prednisone to reduce side effects. Always pair it with prednisone to prevent adrenal insufficiency.
• Take this medicine as prescribed by your doctor, once daily on an empty stomach; food can increase medicine levels.
• It may be combined with testosterone-lowering treatment in earlier stages of prostate cancer.
• Serious risks include adrenal insufficiency, liver toxicity, heart problems, and bone fractures; regular monitoring is essential.
  
• Liver function tests are required before starting the treatment and then regularly.
• This medicine is not for women or children; men must use contraceptives during treatment and after stopping.
• Inform your doctor if you have liver problems, heart disease, high blood pressure, diabetes, allergies, or low potassium.
• Tell your doctor about all medicines, supplements, and herbal products you are taking.
• Since it contains lactose and sodium, let your doctor know if you have lactose intolerance or are on a salt-restricted diet.

• Apothecare Wellness. (n.d.). Buy Xbira 250 mg Tablet Online: Uses, Price, Dosage, Side Effects. Retrieved from the Apothecare website Fizazi, K., Scher, H. I., Molina, A., Logothetis, C. J., Chi, K. N., Jones, R. J.,  & de Bono, J. S. (2012).
  
• Abiraterone acetate for treatment of metastatic castration‑resistant prostate cancer: Final overall survival analysis of the COU‑AA‑301 randomized, double‑blind, placebo‑controlled phase 3 study. Lancet Oncology, 13(10), 983–992 - https://pubmed.ncbi.nlm.nih.gov/22995653/
  
• James, N. D., de Bono, J., Spears, M., Clarke, N. W., Mason, M. D., Dearnaley, D. P., & Attard, G. (2017).
  
• Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer. New England Journal of Medicine, 377(4), 352–360 - https://pubmed.ncbi.nlm.nih.gov/28578607/
  
• Practo. (n.d.). Xbira 250 mg Tablet – Uses, Dosage, Side Effects, Price, Composition. Retrieved from Practo (Indian healthcare platform).
  
• Ryan, C. J., Smith, M. R., de Bono, J., Molina, A., Logothetis, C. J., de Souza, P., & Scher, H. I. (2013). Abiraterone in metastatic prostate cancer without previous chemotherapy. New England Journal of Medicine, 368(2), 138–148.
  
• Tan, G., Xuan, Z., Li, Z., Huang, S., Chen, G., Wu, Y., & Liang, Z. (2020). The efficacy and safety of abiraterone acetate in patients with high‑risk prostate cancer: A meta‑analysis based on six randomized controlled trials. Translational Andrology and Urology, 9(4), 1691–1699.